Heartland Advisors Inc. Takes $12.39 Million Position in DENTSPLY SIRONA Inc. $XRAY

Heartland Advisors Inc. acquired a new stake in DENTSPLY SIRONA Inc. (NASDAQ:XRAY) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 1,167,350 shares of the medical instruments supplier’s stock, valued at approximately $12,386,000.

A number of other large investors have also recently added to or reduced their stakes in XRAY. Eurizon Capital SGR S.p.A. bought a new stake in DENTSPLY SIRONA during the fourth quarter worth approximately $26,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. bought a new position in shares of DENTSPLY SIRONA in the first quarter valued at approximately $26,000. Caitong International Asset Management Co. Ltd lifted its stake in shares of DENTSPLY SIRONA by 337.9% in the third quarter. Caitong International Asset Management Co. Ltd now owns 2,750 shares of the medical instruments supplier’s stock worth $35,000 after buying an additional 2,122 shares during the last quarter. Farther Finance Advisors LLC lifted its stake in shares of DENTSPLY SIRONA by 119.1% in the fourth quarter. Farther Finance Advisors LLC now owns 3,773 shares of the medical instruments supplier’s stock worth $43,000 after buying an additional 2,051 shares during the last quarter. Finally, Performa Ltd US LLC boosted its holdings in shares of DENTSPLY SIRONA by 116.1% during the 4th quarter. Performa Ltd US LLC now owns 4,250 shares of the medical instruments supplier’s stock worth $49,000 after buying an additional 2,283 shares during the period. Institutional investors own 95.70% of the company’s stock.

Insiders Place Their Bets

In other news, Director Michael J. Barber acquired 15,175 shares of the firm’s stock in a transaction dated Thursday, June 11th. The shares were bought at an average price of $9.88 per share, with a total value of $149,929.00. Following the acquisition, the director owned 55,943 shares of the company’s stock, valued at $552,716.84. This trade represents a 37.22% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Brian P. Mckeon acquired 10,000 shares of the stock in a transaction dated Friday, June 12th. The shares were purchased at an average price of $10.12 per share, for a total transaction of $101,200.00. Following the completion of the transaction, the director owned 10,000 shares of the company’s stock, valued at $101,200. This trade represents a ∞ increase in their position. Additional details regarding this purchase are available in the official SEC disclosure. In the last quarter, insiders bought 35,160 shares of company stock worth $351,179. 0.46% of the stock is currently owned by company insiders.

Analyst Ratings Changes

A number of research firms recently issued reports on XRAY. Weiss Ratings reiterated a “sell (e+)” rating on shares of DENTSPLY SIRONA in a research note on Monday, August 3rd. UBS Group cut their target price on shares of DENTSPLY SIRONA from $18.00 to $17.00 and set a “buy” rating for the company in a research report on Thursday, May 7th. BMO Capital Markets restated a “market perform” rating and set a $13.00 price target on shares of DENTSPLY SIRONA in a report on Friday, August 7th. Piper Sandler raised their price target on DENTSPLY SIRONA from $13.00 to $14.00 and gave the company a “neutral” rating in a research report on Wednesday, July 29th. Finally, Mizuho dropped their price objective on DENTSPLY SIRONA from $16.00 to $14.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 6th. Three research analysts have rated the stock with a Buy rating, nine have given a Hold rating and three have given a Sell rating to the stock. According to MarketBeat.com, DENTSPLY SIRONA currently has a consensus rating of “Hold” and an average price target of $13.38.

DENTSPLY SIRONA Stock Up 1.3%

Shares of XRAY opened at $10.92 on Friday. The company has a debt-to-equity ratio of 1.48, a quick ratio of 1.07 and a current ratio of 1.63. The company has a 50-day simple moving average of $12.02 and a 200-day simple moving average of $11.80. DENTSPLY SIRONA Inc. has a 52 week low of $9.40 and a 52 week high of $14.86. The firm has a market capitalization of $2.18 billion, a P/E ratio of -3.97, a P/E/G ratio of 1.36 and a beta of 0.85.

DENTSPLY SIRONA (NASDAQ:XRAY) last released its earnings results on Thursday, August 6th. The medical instruments supplier reported $0.52 earnings per share for the quarter, topping analysts’ consensus estimates of $0.35 by $0.17. DENTSPLY SIRONA had a positive return on equity of 20.84% and a negative net margin of 14.99%.The business had revenue of $898.00 million for the quarter, compared to the consensus estimate of $889.93 million. During the same period last year, the business earned $0.52 earnings per share. The firm’s revenue for the quarter was down 4.1% compared to the same quarter last year. DENTSPLY SIRONA has set its FY 2026 guidance at 1.400-1.500 EPS. On average, equities research analysts expect that DENTSPLY SIRONA Inc. will post 1.41 earnings per share for the current year.

About DENTSPLY SIRONA

Dentsply Sirona Inc (NASDAQ: XRAY) is a leading global manufacturer of professional dental products and technologies. The company, formed through the merger of Dentsply International and Sirona Dental Systems in February 2016, brings together a long heritage of innovation in dental care. Headquartered in Charlotte, North Carolina, Dentsply Sirona develops and markets a comprehensive range of dental consumables, laboratory products, and advanced imaging and CAD/CAM systems.

The company’s product portfolio spans preventive, restorative, orthodontic, endodontic and surgical care.